Hepatocellular carcinoma (HCC), which ranks globally as the third leading cause of cancer-related deaths, is highly prevalent, and most patients are diagnosed with advanced-stage cancer when treatments are largely ineffective. 1 Thus, there is an urgent need for earlier diagnosis to improve HCC patient outcomes.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: